$HIMS

Hims & Hers Health, Inc.

4 analysts · 1 active debates

SENTIMENT

50% BULL

STANCE FLIPS · 7d

LAST VERDICT

BALANCED

NEXT EARNINGS

See filings

AS OF MAY 8

Just In

Latest analyst takes

View all →

Ricky GutierrezBEARHIMS is worth being cautious on because the business isn’t showing a durable competitive edge beyond selling popular ED/GLP-style drugs, so it’s exposed to multiple compression and share-loss versus competitors even if it can bounce on hype.13h ago
Ricky GutierrezBULLHIMS is referenced as a top-performing stock last year but with strong rallies followed by sharp corrections, serving as another example that even winners can reprice quickly once expectations soften.2d ago
Learn to Invest - Investors GrowBULLAdding HIMS to the long-term buy-and-hold portfolio worked out—he paid a little over $19 per share and it’s now around $28–$29, helping the portfolio beat the market by about 15–16%.13d ago

WHERE ANALYSTS DISAGREE ON HIMS

updated 13H AGO

$HIMS

20d

HIMS Short-Term Volatility

BULL CASE

"HIMS is a short‑term rebound winner for recent dip buyers — the stock's massive intraday moves mean buyers at ~$15–17 are already sitting on large gains, though earlier high‑basis holders remain underwater."

Financial EducationANALYST

“Huge Trap Was Just Set for Investors‼️”

Mar 9, 2026

BEAR CASE

"HIMS is breaking down from the highs after a rejection, and if the broader sell-off continues it has meaningful additional downside (he cited roughly 8–9% more)."

Ricky GutierrezANALYST

“Iran War Intensifying | Here's What Happens Next”

Apr 21, 2026

STANCE FLASH · HIMS

— NO STANCE CHANGES THIS WEEK · ANALYSTS STEADY —

ANALYST COVERAGE

— Covered by Ricky Gutierrez · Learn to Invest - Investors Grow

What is the latest research on HIMS?

COMPLETE ANALYSIS HISTORY · 3 TAKES

Ricky Gutierrez13h ago

BEAR$HIMS

"HIMS is worth being cautious on because the business isn’t showing a durable competitive edge beyond selling popular ED/GLP-style drugs, so it’s exposed to multiple compression and share-loss versus competitors even if it can bounce on hype."

"TOP 5 STOCKS TO WATCH THIS WEEK"

Ricky Gutierrez2d ago

BULL$HIMS

"HIMS is referenced as a top-performing stock last year but with strong rallies followed by sharp corrections, serving as another example that even winners can reprice quickly once expectations soften."

@ ~$124.92

"Is Intel a Buy Right Now? Here's What You Need to Know"

Learn to Invest - Investors Grow13d ago

BULL$HIMS

"Adding HIMS to the long-term buy-and-hold portfolio worked out—he paid a little over $19 per share and it’s now around $28–$29, helping the portfolio beat the market by about 15–16%."

@ ~$27.91

"My Investment Portfolio Update 2026"

Hims & Hers Health, Inc.

⚡Just In

HIMS Short-Term Volatility

What is the latest research on HIMS?

Just In